AG-14361

AG-14361

Chemicals & Biochemicals

Article No

BPS-27602-3

Size

50 mg

Shipping Information

Room temp. (continental US) or gel packs

Article No

BPS-27602-3

Size

50 mg

Shipping Information

Room temp. (continental US) or gel packs

Specifications

CAS No 328543-09-5
MW 320.4 Da
Additional Information A 17-hour exposure of A549 cells to 0.4 µM AG14361 does not change the expression of the 6800 genes. Thus, although 0.4 µM AG14361 inhibits cellular PARP-1 activity by more than 85%, it essentially does not change gene expression and cell proliferation, indicating that the cellular effects of this low concentration of AG14361 are specific for PARP-1 inhibition. Higher, growth-inhibitory concentrations of AG14361 affects gene expression, but these effects are not likely to be related to PARP-1 inhibition because cell proliferation is affected equally in PARP-/- and PARP-1+/+ cells.
Article No BPS-27602-3
Country Availability SE, FI, DK, NO, IS, EE, LV, LT
Description AG-14361
Supplier BPS Bioscience
Notes AG14361 is a potent inhibitor of PARP1 with Ki of <5 nM. It is at least 1000-fold more potent than the benzamides. AG14361 treatment before irradiation statistically significantly increases the sensitivity to radiation therapy. AG14361 enhances the growth-inhibitory and cytotoxic effects of topoisomerase I poisons and increases the persistence of camptothecin-induced DNA single-strand breaks.
Molecular Formula C19H20N4O
Alias Names 1-(4-((dimethylamino)methyl)phenyl)-8,9-dihydro-2,7,9a-triazabenzo[cd]azulen-6(7H)-one
Product Type Chemicals & Biochemicals
Purity ≥98% by HPLC
Shipping Information Room temp. (continental US) or gel packs
Size 50 mg
Solubility Soluble in DMSO. Solubility in water or ethanol is <1 mg/ml
Storage Store at or below -20°C. Solid form is stable at least 12 months from date of receipt, when stored as directed. Do not store aqueous solutions for more than one day.
Technical Specifications A 17-hour exposure of A549 cells to 0.4 µM AG14361 does not change the expression of the 6800 genes. Thus, although 0.4 µM AG14361 inhibits cellular PARP-1 activity by more than 85%, it essentially does not change gene expression and cell proliferation, indicating that the cellular effects of this low concentration of AG14361 are specific for PARP-1 inhibition. Higher, growth-inhibitory concentrations of AG14361 affects gene expression, but these effects are not likely to be related to PARP-1 inhibition because cell proliferation is affected equally in PARP-/- and PARP-1+/+ cells.
Product Page Updated 2024-01-09T12:32:15.877Z

Documentation

References

Show more
Shipping info
The delivery time for this item is approximately 5-8 business days. Read more